Jeffery Lewis
Pediatric Gastroenterology · Atlanta, GANPI 1063472967
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (53.2%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Regeneron at 40.5% of the total. Reporting peaked in 2020 at $3,451 and has fallen 93.6% since, to $221 in 2025. Among pediatric gastroenterology clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 78 payments — averaging $109.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron$3K
- QOL Medical, LLC$2K
- Sanofi$1K
- Bristol Myers Squibb$434
- Janssen Scientific Affairs, LLC$357
- Sanofi-aventis U.S. LLC$280
- plus $931 from 16 others
Across 89 payments — averaging $8766.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$286K
- Bristol Myers Squibb$255K
- Janssen Research & Development, LLC$175K
- AbbVie$41K
- Merck$23K
What the payments were for
- Consulting fees$4,53653%
- Speaking & faculty fees$1,70020%
- Food & beverage$2,28127%
- Education$40%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron | 16 | $3,453 |
| QOL Medical, LLC | 5 | $1,672 |
| Sanofi | 10 | $1,394 |
| Bristol Myers Squibb | 4 | $434 |
| Janssen Scientific Affairs, LLC | 3 | $357 |
| Sanofi-aventis U.S. LLC | 3 | $280 |
| Shire North American Group Inc | 1 | $200 |
| AbbVie | 7 | $130 |
| Novo Nordisk | 1 | $125 |
| Regeneron Healthcare Solutions, Inc. | 3 | $86 |
| Johnson & Johnson | 5 | $76 |
| Janssen Research & Development, LLC | 1 | $42 |
| Biocon Biologics Inc | 2 | $40 |
| Amgen(2 entities) | 2 | $40 |
| Mirum Pharmaceuticals, Inc. | 2 | $39 |
| Fresenius Kabi USA, LLC | 2 | $38 |
| Galen US Inc | 1 | $32 |
| Ipsen Biopharmaceuticals, Inc | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Travere Therapeutics, Inc. | 6 | $15 |
| Ironwood Pharmaceuticals, Inc | 1 | $14 |
| Merck | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,521 in reported general payments places this provider in the 90th percentile of 44 pediatric gastroenterology providers in Georgia.
Other pediatric gastroenterology in Atlanta
- Benjamin GoldAtlanta$79K
- Subramaniam KugathasanAtlanta$47K
- Nitika GuptaAtlanta$28K
- Stanley CohenAtlanta$25K
- Rene RomeroAtlanta$7K
- Seth MarcusAtlanta$7K
- Jeffrey BlumenthalAtlanta$2K
- Nirav PatelAtlanta$2K
- Tejas MehtaAtlanta$2K
- Steven LiuAtlanta$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.